2012, Number 1
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2012; 10 (1)
Corticoesteroid dependent genital syndrome
Poletti VED, Muñoz SR, Morales MA
Language: Spanish
References: 17
Page: 21-24
PDF size: 141.67 Kb.
ABSTRACT
The redness syndrome in the genital area is a local, chronic and
symptomatic disease, secondary to corticoid dependence, in
both sexes, and it should be considered as part of therapeutic
actions. We present two cases of the syndrome with inappropriate
application of topical corticosteroids, a 34-year-old man,
and a 42-year-old woman, both previously healthy, with scrotal
and vulvar disease, respectively.
REFERENCES
Wolverton SE. Comprehensive Dermatologic Drug Therapy. 2a ed. Philadelphia, Saunders Elsevier, 2007: 132, 142-147.
Sterry W. “Therapy with topical corticosteroids”. Arch Dermatol Res 1992; 284 (Suppl 1): S27-S29.
Wong VK, Della Croce C, Schonfeld S, Mastrangelo AM, Lebwohl M. “Use and abuse of topical corticosteroids in infections of the skin and related structures”. J Drugs Dermatol 2003: 2: 268-276.
Fisher BK. “The Red Scrotum Syndrome”. Cutis 1997; 60(3): 139-141.
Fisher BK, Margsesson L J. Genital Skin Disorders. 1a ed. St. Louis, Missouri, Mosby, 1998: 53-54, 157-159.
Habif T. Clinical Dermatology. 5a ed. Hanover, Mosby-Elsevier, 2010: 56-59, 115-118.
Harris JR. “Male genital pain syndrome”. Dermatol Clin 1998; 16: 779-782.
Parricha JS, Gupta R. “Contact sensitivity to betamethasone 17-valerate and fluocinolone acetonide”. Contact Dermatitis 1983; 9(4): 330-331.
Shelley B, Shelley ED. Advanced Dermatological Diagnosis. Philadelphia, WB Saunders, 1992: 614-620.
Elder DE, Elenitasas R, Johnson B, Ioffreda M, Miller J. et al. Lever´s Histopathology of the Skin. 2a ed. Philadephia, Lippincot, Williams & Wilkins, 2007: 153-167.
Bolognia, JL, Jorizzo JL, Rapini RP et al. Dermatology, 2a ed. Londres, Mosby-Elsevier, 2008: 100, 1069-1070.
Kling C, Obadiah J. “Corticosteroid- dependent scrotum”. J Am Acad Derm 2005; 52(3): 447.
Lebowl, MG., Heymann WR, Berth-Jonez J, Coulson I. Treatment of skin disease, comprehensive therapeutic strategies. 2a ed. Philadelphia, Mosby Elsevier, 2006: 392.
Charman CR, Morris AD, Williams HC. “Topical corticosteroid phobia in patients with atopic eczema”. Br J Dermatol 2000; 142: 931-936.
Patterson R, Walker CL, Greenberger PA, Sheridan EP. Prednisonephobia. Allergy Proc , 1989; 10: 423-428.
Fonseca CE. “Fobias y filias en el tratamiento con corticoides tópicos”. Piel 2004; 19(8): 405-406.
Wolf K, Goldsmith LA, Katz SI, Gilchrest AS, et al. Fitzpatrick’s Dermatology in general medicine. 7a ed. Nueva York, McGraw- Hill, 2008: 670, 2102-2106.
Full text